» Articles » PMID: 38558722

Light-Chain (AL) Cardiac Amyloidosis Presenting As Heart Failure With Reduced Ejection Fraction

Overview
Journal Cureus
Date 2024 Apr 1
PMID 38558722
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic amyloidosis is caused by the extracellular deposition of misfolded proteins in various organs and usually leads to organ dysfunction. The two common subtypes include light-chain amyloidosis and transthyretin amyloidosis. Deposition of these proteins in the heart can lead to infiltrative and restrictive cardiomyopathy, commonly manifesting as heart failure with preserved ejection fraction. However, systolic heart failure with reduced ejection fraction is mainly seen in the advanced stages of the disease. Here, we present the case of a 53-year-old female who presented with new-onset heart failure with reduced ejection fraction with no prior symptoms or diagnosis of amyloidosis and diastolic dysfunction.

References
1.
Rubin J, Maurer M . Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Annu Rev Med. 2020; 71:203-219. DOI: 10.1146/annurev-med-052918-020140. View

2.
Bosah A, Tobaa A, Gajjar K, Kashyap K, Alpert C . Acute Decompensated Heart Failure Due to Combined Ischemic Cardiomyopathy and Cardiac Amyloidosis. Cureus. 2023; 14(12):e32281. PMC: 9816919. DOI: 10.7759/cureus.32281. View

3.
Singh V, Falk R, Di Carli M, Kijewski M, Rapezzi C, Dorbala S . State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2018; 26(1):158-173. PMC: 6541031. DOI: 10.1007/s12350-018-01552-4. View

4.
Sipe J, Benson M, Buxbaum J, Ikeda S, Merlini G, Saraiva M . Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid. 2016; 23(4):209-213. DOI: 10.1080/13506129.2016.1257986. View

5.
Castano A, Narotsky D, Hamid N, Khalique O, Morgenstern R, DeLuca A . Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J. 2017; 38(38):2879-2887. PMC: 5837725. DOI: 10.1093/eurheartj/ehx350. View